Fig. 1From: Distinct sex-specific DNA methylation differences in Alzheimer’s diseaseSex-specific meta-analysis of female samples identified 2 CpGs significantly associated with AD diagnosis at 5% false discovery rate (FDR). a The CpG cg18020072, located on the PRRC2A gene, is significantly associated with AD diagnosis in females (P-value = 3.02 × 10−8, FDR = 0.023). b The CpG cg24276069, located on the RPS8 gene, is also significantly associated with AD diagnosis in females (P-value = 9.62 × 10−8, FDR = 0.036). FDR: false discovery rateBack to article page